|
1
|
Foessl I, Dimai HP and Obermayer-Pietsch
B: Long-term and sequential treatment for osteoporosis. Nat Rev
Endocrinol. 19:520–533. 2023.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Liu L, Zhang J, Cheng Y, Zhu M, Xiao Z,
Ruan G and Wei Y: Gut microbiota: A new target for T2DM prevention
and treatment. Front Endocrinol (Lausanne).
13(958218)2022.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Tomasiuk JM, Nowakowska-Płaza A, Wisłowska
M and Głuszko P: Osteoporosis and diabetes-possible links and
diagnostic difficulties. Reumatologia. 61:294–304. 2023.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Liu X, Chen F, Liu L and Zhang Q:
Prevalence of osteoporosis in patients with diabetes mellitus: A
systematic review and meta-analysis of observational studies. BMC
Endocr Disord. 23(1)2023.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Chen HL, Deng LL and Li JF: Prevalence of
osteoporosis and its associated factors among older men with type 2
diabetes. Int J Endocrinol. 2013(285729)2013.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Zhou Y, Li Y, Zhang D, Wang J and Yang H:
Prevalence and predictors of osteopenia and osteoporosis in
postmenopausal Chinese women with type 2 diabetes. Diabetes Res
Clin Pract. 90:261–269. 2010.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Zhang X, Xu D, Zhang R, Wang H and Yang G:
Interaction between diabetes and osteoporosis: Imbalance between
inflammation and bone remodeling. Osteoporos Int. 36:2401–2409.
2025.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Jiang L, Song X, Yan L, Liu Y, Qiao X and
Zhang W: Molecular insights into the interplay between type 2
diabetes mellitus and osteoporosis: Implications for endocrine
health. Front Endocrinol (Lausanne). 15(1483512)2025.PubMed/NCBI View Article : Google Scholar
|
|
9
|
An Y, Zhang H, Wang C, Jiao F, Xu H, Wang
X, Luan W, Ma F, Ni L, Tang X, et al: Activation of
ROS/MAPKs/NF-κB/NLRP3 and inhibition of efferocytosis in
osteoclast-mediated diabetic osteoporosis. FASEB J. 33:12515–12527.
2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Umur E, Bulut SB, Yiğit P, Bayrak E, Arkan
Y, Arslan F, Baysoy E, Kaleli-Can G and Ayan B: Exploring the role
of hormones and cytokines in osteoporosis development.
Biomedicines. 12(1830)2024.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Kanazawa I: Osteocalcin as a hormone
regulating glucose metabolism. World J Diabetes. 6:1345–1354.
2015.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Zhang C, Li H, Li J, Hu J, Yang K and Tao
L: Oxidative stress: A common pathological state in a high-risk
population for osteoporosis. Biomed Pharmacother.
163(114834)2023.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Shi C, Wu J, Yan Q, Wang R and Miao D:
Bone marrow ablation demonstrates that estrogen plays an important
role in osteogenesis and bone turnover via an antioxidative
mechanism. Bone. 79:94–104. 2015.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Ming Y, He X, Zhao Z, Meng X, Zhu Y, Tan
H, Yang G, Hu Y and Zheng L: Nanocarrier-assisted delivery of
berberine promotes diabetic alveolar bone regeneration by
scavenging ROS and improving mitochondrial dysfunction. Int J
Nanomedicine. 19:10263–10282. 2024.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Zhao R, Xiong C, Zhao Z, Zhang J, Huang Y,
Xie Z, Qu X, Luo X and Li Z: Exploration of the shared Hub genes
and biological mechanism in osteoporosis and type 2 diabetes
mellitus based on machine learning. Biochem Genet. 61:2531–2547.
2023.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Li X, Li Y and Lei C: Effects of
glucagon-like peptide-1 receptor agonists on bone metabolism in
type 2 diabetes mellitus: A systematic review and meta-analysis.
Int J Endocrinol. 2024(1785321)2024.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Lin R, Xu B, Ye Z, Gao Y, Fang H, Song J,
Liang D, Liu L, Hu Z, Zhang M, et al: Metformin attenuates
diabetes-induced osteopenia in rats is associated with
down-regulation of the RAGE-JAK2-STAT1 signal axis. J Orthop
Translat. 40:37–48. 2023.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Tan Y, Liu S and Tang Q: Effect of GLP-1
receptor agonists on bone mineral density, bone metabolism markers,
and fracture risk in type 2 diabetes: A systematic review and
meta-analysis. Acta Diabetol. 62:589–606. 2025.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Chen PW, Su HY, Tu YK, Wu CH, Yeh JI, Chen
LY, Peng CC, Loh CH, Huang HK and Lin SM: Association of
bisphosphonates with diabetes risk and glycemic control: A
meta-analysis. Osteoporos Int. 34:387–397. 2023.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Huang HK, Chuang AT, Liao TC, Shao SC, Liu
PP, Tu YK and Lai EC: Denosumab and the risk of diabetes in
patients treated for osteoporosis. JAMA Netw Open.
7(e2354734)2024.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Wade SW, Strader C, Fitzpatrick LA,
Anthony MS and O'Malley CD: Estimating prevalence of osteoporosis:
Examples from industrialized countries. Arch Osteoporos.
9(182)2014.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Salari N, Darvishi N, Bartina Y, Larti M,
Kiaei A, Hemmati M, Shohaimi S and Mohammadi M: Global prevalence
of osteoporosis among the world older adults: A comprehensive
systematic review and meta-analysis. J Orthop Surg Res.
16(669)2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Martiniakova M, Biro R, Penzes N, Sarocka
A, Kovacova V, Mondockova V and Omelka R: Links among obesity, type
2 diabetes mellitus, and osteoporosis: Bone as a target. Int J Mol
Sci. 25(4827)2024.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Chai S, Yang Y, Wei L, Cao Y, Ma J, Zheng
X, Teng J and Qin N: Luteolin rescues postmenopausal osteoporosis
elicited by OVX through alleviating osteoblast pyroptosis via
activating PI3K-AKT signaling. Phytomedicine.
128(155516)2024.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Li Y, Teng D, Shi X, Qin G, Qin Y, Quan H,
Shi B, Sun H, Ba J, Chen B, et al: Prevalence of diabetes recorded
in mainland China using 2018 diagnostic criteria from the American
diabetes association: National cross sectional study. BMJ.
369(m997)2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Si Y, Wang C, Guo Y, Xu G and Ma Y:
Prevalence of osteoporosis in patients with type 2 diabetes
mellitus in the chinese mainland: A systematic review and
meta-analysis. Iran J Public Health. 48:1203–1214. 2019.PubMed/NCBI
|
|
27
|
Abdulameer SA, Sulaiman SAS, Hassali MAA,
Subramaniam K and Sahib MN: Osteoporosis and type 2 diabetes
mellitus: What do we know, and what we can do? Patient Prefer
Adherence. 6:435–448. 2012.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Kupai K, Kang HL, Pósa A, Csonka Á,
Várkonyi T and Valkusz Z: Bone loss in diabetes mellitus:
Diaporosis. Int J Mol Sci. 25(7269)2024.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Cipriani C, Colangelo L, Santori R,
Renella M, Mastrantonio M, Minisola S and Pepe J: The interplay
between bone and glucose metabolism. Front Endocrinol (Lausanne).
11(122)2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Zhang X, Krishnamoorthy S, Tang CTL, Hsu
WWQ, Li GHY, Sing CW, Tan KCB, Cheung BMY, Wong ICK, Kung AWC and
Cheung CL: Association of bone mineral density and bone turnover
markers with the risk of diabetes: Hong kong osteoporosis study and
mendelian randomization. J Bone Miner Res. 38:1782–1790.
2023.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Chen F, Wang P, Dai F, Zhang Q, Ying R, Ai
L and Chen Y: Correlation between blood glucose fluctuations and
osteoporosis in type 2 diabetes mellitus. Int J Endocrinol.
2025(8889420)2025.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Li JQ, Li B, Fei ZQ and Lei SS:
Understanding the relationship between inflammation, apoptosis, and
diabetes osteoporosis: A bioinformatics approach and experimental
verification. FASEB J. 38(e70074)2024.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Heo YJ, Park J, Lee N, Choi SE, Jeon JY,
Han SJ, Kim DJ, Lee KW and Kim HJ: Cysteine-rich 61 inhibition
attenuates hepatic insulin resistance and improves lipid metabolism
in high-fat diet fed mice and HepG2 cells. FASEB J.
38(e23859)2024.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Du X, Liu M, Tai W, Yu H, Hao X, Loor JJ,
Jiang Q, Fang Z, Gao X, Fan M, et al: Tumor necrosis factor-α
promotes lipolysis and reduces insulin sensitivity by activating
nuclear factor kappa B and c-Jun N-terminal kinase in primary
bovine adipocytes. J Dairy Sci. 105:8426–8438. 2022.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Berbudi A, Khairani S and Tjahjadi AI:
Interplay between insulin resistance and immune dysregulation in
type 2 diabetes mellitus: Implications for therapeutic
interventions. Immunotargets Ther. 14:359–382. 2025.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Sun D, Zhao Y and Wu X: Effects of tumor
necrosis factor-α on glucose uptake in human granulosa cells under
high androgen conditions. Iran J Basic Med Sci. 26:912–918.
2023.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Piprode V, Behera S, Karhade J, Mhaske ST
and Wani MR: Priming of mouse pre-osteoblasts with Interleukin-3
attenuates TNF-α-induced-inhibition of osteoblast differentiation.
BMC Musculoskelet Disord. 26(663)2025.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Du J, Zhou W, Sun Z, Zhang W, Luo W and
Liu S: Peroxiredoxin 1 promotes proliferation and inhibits
differentiation of MC3T3-E1 cells via AKT1/NF-κB signaling pathway.
J Oral Biosci. 66:403–411. 2024.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Boyce BF, Li J, Yao Z and Xing L: Nuclear
factor-kappa B regulation of osteoclastogenesis and
osteoblastogenesis. Endocrinol Metab (Seoul). 38:504–521.
2023.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Salvadori L, Belladonna ML, Castiglioni B,
Paiella M, Panfili E, Manenti T, Ercolani C, Cornioli L,
Chiappalupi S, Gentili G, et al: KYMASIN up natural product
inhibits osteoclastogenesis and improves osteoblast activity by
modulating Src and p38 MAPK. Nutrients. 14(3053)2022.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Yan H, He L, Lv D, Yang J and Yuan Z: The
role of the dysregulated JNK signaling pathway in the pathogenesis
of human diseases and its potential therapeutic strategies: A
comprehensive review. Biomolecules. 14(243)2024.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Fleming Y, Armstrong CG, Morrice N,
Paterson A, Goedert M and Cohen P: Synergistic activation of
stress-activated protein kinase 1/c-Jun N-terminal kinase
(SAPK1/JNK) isoforms by mitogen-activated protein kinase kinase 4
(MKK4) and MKK7. Biochem J. 352:145–154. 2000.PubMed/NCBI
|
|
43
|
Zeke A, Misheva M, Reményi A and
Bogoyevitch MA: JNK signaling: Regulation and functions based on
complex protein-protein partnerships. Microbiol Mol Biol Rev.
80:793–835. 2016.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Henstridge DC, Bruce CR, Pang CP,
Lancaster GI, Allen TL, Estevez E, Gardner T, Weir JM, Meikle PJ,
Lam KSL, et al: Skeletal muscle-specific overproduction of
constitutively activated c-Jun N-terminal kinase (JNK) induces
insulin resistance in mice. Diabetologia. 55:2769–2778.
2012.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Hilder TL, Tou JCL, Grindeland RE, Wade CE
and Graves LM: Phosphorylation of insulin receptor substrate-1
serine 307 correlates with JNK activity in atrophic skeletal
muscle. FEBS Lett. 553:63–67. 2003.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Klejbuk K and Strączkowski M:
Interleukin-38 and insulin resistance. Endocr Metab Immune Disord
Drug Targets. 24:611–616. 2024.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Kuroyanagi G, Hioki T,
Matsushima-Nishiwaki R, Kozawa O and Tokuda H: Gallein increases
the fibroblast growth factor 2-elicited osteoprotegerin synthesis
in osteoblasts. Biochim Biophys Acta Gen Subj.
1868(130635)2024.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Sepulveda H, Villagra A and Montecino M:
Tet-mediated DNA demethylation is required for SWI/SNF-dependent
chromatin remodeling and histone-modifying activities that trigger
expression of the Sp7 osteoblast master gene during mesenchymal
lineage commitment. Mol Cell Biol. 37:e00177–17. 2017.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Dong Y, Song K, Wang P, Guo J, Kang H, Tan
X, Zhu B, Peng R, Zhu M, Yu K, et al: Blocking the cytohesin-2/ARF1
axis by SecinH3 ameliorates osteoclast-induced bone loss via
attenuating JNK-mediated IRE1 endoribonuclease activity. Pharmacol
Res. 185(106513)2022.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Luo N, Zhang L, Xiu C, Luo X, Hu S, Ji K,
Liu Q and Chen J: Piperlongumine, a Piper longum-derived amide
alkaloid, protects mice from ovariectomy-induced osteoporosis by
inhibiting osteoclastogenesis via suppression of p38 and JNK
signaling. Food Funct. 15:2154–2169. 2024.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Fujishiro M, Gotoh Y, Katagiri H, Sakoda
H, Ogihara T, Anai M, Onishi Y, Ono H, Abe M, Shojima N, et al:
Three mitogen-activated protein kinases inhibit insulin signaling
by different mechanisms in 3T3-L1 adipocytes. Mol Endocrinol.
17:487–497. 2003.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Rui L, Yuan M, Frantz D, Shoelson S and
White MF: SOCS-1 and SOCS-3 block insulin signaling by
ubiquitin-mediated degradation of IRS1 and IRS2. J Biol Chem.
277:42394–42398. 2002.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Ye J, Zheng R, Wang Q, Liao L, Ying Y, Lu
H, Cianflone K, Ning Q and Luo X: Downregulating SOCS3 with siRNA
ameliorates insulin signaling and glucose metabolism in hepatocytes
of IUGR rats with catch-up growth. Pediatr Res. 72:550–559.
2012.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Ma R, Quan L, Aleteng QQS, Li L, Zhu J and
Jiang S: The impact of sitagliptin in palmitic acid-induced insulin
resistance in human HepG2 cells through the suppressor of cytokine
signaling 3/phosphoinositide 3-kinase/protein kinase B pathway. J
Physiol Pharmacol. 74:159–168. 2023.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Wang Z, Wang Y, Tang Y, Guo X, Gao Q, Shao
Y, Wang J, Tian R and Shi Y: Sodium benzoate inhibits osteoblast
differentiation and accelerates bone loss by regulating the
FGF2/p38/RUNX2 pathway. J Agric Food Chem. 73:13891–13901.
2025.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Yang W, Guo J, Song J and Guo S: Studies
of foxo1 over the past 25 years: Mechanisms of insulin resistance
and glucose dysregulation. Cells. 15(109)2026.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Miao H, Zhang Y, Lu Z, Liu Q and Gan L:
FOXO1 involvement in insulin resistance-related pro-inflammatory
cytokine production in hepatocytes. Inflamm Res. 61:349–358.
2012.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Webb AE and Brunet A: FOXO transcription
factors: Key regulators of cellular quality control. Trends Biochem
Sci. 39:159–169. 2014.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Asada S, Daitoku H, Matsuzaki H, Saito T,
Sudo T, Mukai H, Iwashita S, Kako K, Kishi T, Kasuya Y and Fukamizu
A: Mitogen-activated protein kinases, Erk and p38, phosphorylate
and regulate Foxo1. Cell Signal. 19:519–527. 2007.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Yang CM, Yang CC, Hsu WH, Hsiao LD, Tseng
HC and Shih YF: Tumor necrosis factor-α-induced C-C motif chemokine
ligand 20 expression through TNF receptor 1-dependent activation of
EGFR/p38 MAPK and JNK1/2/FoxO1 or the NF-κB pathway in human
cardiac fibroblasts. Int J Mol Sci. 23(9086)2022.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Yuan W, Lin H, Sun Y, Liu L, Yan M, Song
Y, Zhang X, Lu X, Xu Y, He Q, et al: Myocardin reverses insulin
resistance and ameliorates cardiomyopathy by increasing IRS-1
expression in a murine model of lipodystrophy caused by adipose
deficiency of vacuolar H+-ATPase V0d1 subunit.
Theranostics. 14:2246–2264. 2024.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Zhang Y, Jin W, Zhang D, Lin C, He H, Xie
F, Gan L, Fu W, Wu L and Wu Y: TNF-α antagonizes the effect of
leptin on insulin secretion through FOXO1-dependent transcriptional
suppression of LepRb in INS-1 cells. Oxid Med Cell Longev.
2022(9142798)2022.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Liu C, Zheng Y, Hu S, Liang X, Li Y, Yu Z,
Liu Y, Bian Y, Man Y, Zhao S, et al: TOX3 deficiency mitigates
hyperglycemia by suppressing hepatic gluconeogenesis through FoxO1.
Metabolism. 152(155766)2024.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Tsuchiya K and Ogawa Y: Forkhead box class
O family member proteins: The biology and pathophysiological roles
in diabetes. J Diabetes Investig. 8:726–734. 2017.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Yang S, Xu H, Yu S, Cao H, Fan J, Ge C,
Fransceschi RT, Dong HH and Xiao G: Foxo1 mediates insulin-like
growth factor 1 (IGF1)/insulin regulation of osteocalcin expression
by antagonizing Runx2 in osteoblasts. J Biol Chem. 286:19149–19158.
2011.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Cui W, Yang X, Dou Y, Du Y, Ma X, Hu L and
Lin Y: Effects of tetrahedral DNA nanostructures on the treatment
of osteoporosis. Cell Prolif. 57(e13625)2024.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Xue L, Xu J, Xiao P, Jiang Y, Lin Y, Feng
C, Jin Y, Zhou Z, Wang G and Lu D: Perfluorooctane sulfonate (PFOS)
induced bone loss by inhibiting FoxO1-mediated defense against
oxidative stress in osteoblast. Ecotoxicol Environ Saf.
290(117524)2025.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Li T and Gao SJ: KSHV hijacks FoxO1 to
promote cell proliferation and cellular transformation by
antagonizing oxidative stress. J Med Virol.
95(e28676)2023.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Hofbauer LC, Kühne CA and Viereck V: The
OPG/RANKL/RANK system in metabolic bone diseases. J Musculoskelet
Neuronal Interact. 4:268–275. 2004.PubMed/NCBI
|
|
70
|
Chi G, Qiu L, Ma J, Wu W and Zhang Y: The
association of osteoprotegerin and RANKL with osteoporosis: A
systematic review with meta-analysis. J Orthop Surg Res.
18(839)2023.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Park JH, Lee NK and Lee SY: Current
understanding of RANK signaling in osteoclast differentiation and
maturation. Mol Cells. 40:706–713. 2017.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Asagiri M and Takayanagi H: The molecular
understanding of osteoclast differentiation. Bone. 40:251–264.
2007.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Feng X: RANKing intracellular signaling in
osteoclasts. IUBMB Life. 57:389–395. 2005.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Zhao Y, Wang HL, Li TT, Yang F and Tzeng
CM: Baicalin ameliorates dexamethasone-induced osteoporosis by
regulation of the RANK/RANKL/OPG signaling pathway. Drug Des Devel
Ther. 14:195–206. 2020.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Wu MH, Hsu WB, Chen MH and Shi CS:
Inhibition of neddylation suppresses osteoclast differentiation and
function in vitro and alleviates osteoporosis in vivo.
Biomedicines. 10(2355)2022.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Kim JH, Kim K, Kim I, Seong S, Kook H, Kim
KK, Koh JT and Kim N: Bifunctional role of CrkL during bone
remodeling. Int J Mol Sci. 22(7007)2021.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Gu Y, Hou T, Qin Y and Dong W: Zoledronate
promotes osteoblast differentiation in high-glucose conditions via
the p38MAPK pathway. Cell Biol Int. 47:216–227. 2023.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Onoki T, Kanczler J, Rawlings A, Smith M,
Kim YH, Hashimoto K, Aizawa T and Oreffo ROC: Modulation of
osteoblastogenesis by NRF2: NRF2 activation suppresses osteogenic
differentiation and enhances mineralization in human bone
marrow-derived mesenchymal stromal cells. FASEB J.
38(e23892)2024.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Yu J, Tian N, Hu Y and Jin T: RANKL/RANK
contributes to the pathological process of type 2 diabetes mellitus
through TRAF3 activation of NIK. Int Immunopharmacol.
142(113008)2024.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Kondegowda NG, Filipowska J, Do JS,
Leon-Rivera N, Li R, Hampton R, Ogyaadu S, Levister C, Penninger
JM, Reijonen H, et al: RANKL/RANK is required for cytokine-induced
beta cell death; osteoprotegerin, a RANKL inhibitor, reverses
rodent type 1 diabetes. Sci Adv. 9(eadf5238)2023.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Kiechl S, Wittmann J, Giaccari A, Knoflach
M, Willeit P, Bozec A, Moschen AR, Muscogiuri G, Sorice GP, Kireva
T, et al: Blockade of receptor activator of nuclear factor-κB
(RANKL) signaling improves hepatic insulin resistance and prevents
development of diabetes mellitus. Nat Med. 19:358–363.
2013.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Jo S, Pritchard S, Wong A, Avula N, Essawy
A, Hanover J and Alejandro EU: Pancreatic β-cell
hyper-O-GlcNAcylation leads to impaired glucose homeostasis in
vivo. Front Endocrinol (Lausanne). 13(1040014)2022.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Cao L and Wang J: Roles of Wnt/β-catenin
signaling in osteoporosis, disease pathogenesis, and natural
compound intervention. Biomol Ther (Seoul). 34:65–79.
2026.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Nie X, Wei X, Ma H, Fan L and Chen WD: The
complex role of Wnt ligands in type 2 diabetes mellitus and related
complications. J Cell Mol Med. 25:6479–6495. 2021.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Vlashi R, Zhang X, Wu M and Chen G: Wnt
signaling: Essential roles in osteoblast differentiation, bone
metabolism and therapeutic implications for bone and skeletal
disorders. Genes Dis. 10:1291–1317. 2022.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Abou Azar F and Lim GE: Metabolic
contributions of Wnt signaling: More than controlling flight. Front
Cell Dev Biol. 9(709823)2021.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Zhang DH and Shao J: Research progress of
basing on Wnt/β-catenin pathway in the treatment of bone tissue
diseases. Tissue Eng Part B Rev. 31:555–565. 2025.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Krishnan V, Bryant HU and Macdougald OA:
Regulation of bone mass by Wnt signaling. J Clin Invest.
116:1202–1209. 2006.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Riddle RC, Diegel CR, Leslie JM, Van
Koevering KK, Faugere MC, Clemens TL and Williams BO: Lrp5 and Lrp6
exert overlapping functions in osteoblasts during postnatal bone
acquisition. PLoS One. 8(e63323)2013.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Komori T: Regulation of osteoblast
differentiation by transcription factors. J Cell Biochem.
99:1233–1239. 2006.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Jiang H, Xi Y, Jiang Q, Dai W, Qin X,
Zhang J, Jiang Z, Yang G and Chen Q: LRP5 down-regulation
exacerbates inflammation and alveolar bone loss in periodontitis by
inhibiting PI3K/c-FOS signalling. J Clin Periodontol. 52:637–650.
2025.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Dong Y, Hu X, Liu W, Hao Y, Zhou J, Li X
and Wang B: Fibroblast activation protein-α interacts with CXCL12
to inactivate canonical Wnt signaling and regulate osteoblast
differentiation. Stem Cells. 43(sxaf027)2025.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Deng L, Li X, Ren X, Lai S, Zhu Y, Li J,
Huang H and Mu Y: A grooved porous hydroxyapatite scaffold induces
osteogenic differentiation via regulation of PKA activity by
upregulating miR-129-5p expression. J Periodontal Res.
57:1238–1255. 2022.PubMed/NCBI View Article : Google Scholar
|
|
94
|
Jin CY, Guo YY, Hou XM and Tang ZH: Small
molecule nitazoxanide inhibits osteogenic differentiation and
promotes adipogenic differentiation of bone marrow mesenchymal stem
cells. Chin J Dent Res. 26:69–75. 2023.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Lee SJ, Jang SA, Kim SC, Gu DR, Yang H,
Ryuk JA and Ha H: Euonymus alatus (Thunb.) siebold prevents
osteoclast differentiation and osteoporosis. Nutrients.
15(3996)2023.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Napolitano T, Silvano S, Ayachi C,
Plaisant M, Sousa-Da-Veiga A, Fofo H, Charles B and Collombat P:
Wnt pathway in pancreatic development and pathophysiology. Cells.
12(565)2023.PubMed/NCBI View Article : Google Scholar
|
|
97
|
Liu Z and Habener JF: Wnt signaling in
pancreatic islets. Adv Exp Med Biol. 654:391–419. 2010.PubMed/NCBI View Article : Google Scholar
|
|
98
|
Adeerjiang Y, Sidike A, Gan XX, Li QT and
Jiang S: The role of Wnt3a/β-catenin/TCF7L2 pathway in diabetes and
cardiorenal complications. Cardiorenal Med. 15:72–82.
2025.PubMed/NCBI View Article : Google Scholar
|
|
99
|
Katsumoto K, Yennek S, Chen C, Silva LFD,
Traikov S, Sever D, Azad A, Shan J, Vainio S, Ninov N, et al: Wnt4
is heterogeneously activated in maturing β-cells to control calcium
signaling, metabolism and function. Nat Commun.
13(6255)2022.PubMed/NCBI View Article : Google Scholar
|
|
100
|
Ndandala CB, Zhou Q, Li Z, Guo Y, Li G and
Chen H: Identification of insulin-like growth factor (IGF) family
genes in the golden pompano, trachinotus ovatus: Molecular cloning,
characterization and gene expression. Int J Mol Sci.
25(2499)2024.PubMed/NCBI View Article : Google Scholar
|
|
101
|
Fang J, Zhang X, Chen X, Wang Z, Zheng S,
Cheng Y, Liu S and Hao L: The role of insulin-like growth factor-1
in bone remodeling: A review. Int J Biol Macromol.
238(124125)2023.PubMed/NCBI View Article : Google Scholar
|
|
102
|
Rajpathak SN, Gunter MJ, Wylie-Rosett J,
Ho GY, Kaplan RC, Muzumdar R, Rohan TE and Strickler HD: The role
of insulin-like growth factor-I and its binding proteins in glucose
homeostasis and type 2 diabetes. Diabetes Metab Res Rev. 25:3–12.
2009.PubMed/NCBI View Article : Google Scholar
|
|
103
|
Chou CH and Barton ER: Phosphorylation of
AMPKα at Ser485/491 is dependent on muscle contraction and not
muscle-specific IGF-I overexpression. Int J Mol Sci.
24(11950)2023.PubMed/NCBI View Article : Google Scholar
|
|
104
|
Thankamony A, Capalbo D, Marcovecchio ML,
Sleigh A, Jørgensen SW, Hill NR, Mooslehner K, Yeo GS, Bluck L,
Juul A, et al: Low circulating levels of IGF-1 in healthy adults
are associated with reduced β-cell function, increased
intramyocellular lipid, and enhanced fat utilization during
fasting. J Clin Endocrinol Metab. 99:2198–2207. 2014.PubMed/NCBI View Article : Google Scholar
|
|
105
|
Wu YW, Wu CY, Lin F and Wu JY: Exercise
training benefits pancreatic islet by modulating the insulin-like
growth factor 1/phosphatidylinositol 3-kinase/protein kinase B
pathway. World J Diabetes. 16(101447)2025.PubMed/NCBI View Article : Google Scholar
|
|
106
|
Xiao S, Rao L, Yan C, Nie L, Wang L, Zhao
Y, Zhang S, Zhan W, Qin D and Zhuang M: Aptamer functionalized
liposomes co-loaded with exenatide-4 and coenzyme Q10 ameliorate
type 2 diabetes mellitus by improving pancreatic β cell function.
Int J Nanomedicine. 20:3363–3378. 2025.PubMed/NCBI View Article : Google Scholar
|
|
107
|
Li H, Chen Q, Yang W, Deng Y, Zhao L and
Zeng Z: PPARγ alleviates damage to chorionic trophoblast cells
induced by high glucose and high lipids through regulation of
IGF-1. Adv Clin Exp Med. 34:959–971. 2025.PubMed/NCBI View Article : Google Scholar
|
|
108
|
Lee DO, Jee BC, Ku SY, Suh CS, Kim SH,
Choi YM, Moon SY and Kim JG: Relationships between the insulin-like
growth factor I (IGF-I) receptor gene G3174A polymorphism, serum
IGF-I levels, and bone mineral density in postmenopausal Korean
women. J Bone Miner Metab. 26:42–46. 2008.PubMed/NCBI View Article : Google Scholar
|
|
109
|
Mao D, Wang K, Jiang H, Mi J, Pan X, Zhao
G and Rui Y: Suppression of overactive insulin-like growth factor 1
attenuates trauma-induced heterotopic ossification in mice. Am J
Pathol. 194:430–446. 2024.PubMed/NCBI View Article : Google Scholar
|
|
110
|
Vestergaard P: Bone metabolism in type 2
diabetes and role of thiazolidinediones. Curr Opin Endocrinol
Diabetes Obes. 16:125–131. 2009.PubMed/NCBI View Article : Google Scholar
|
|
111
|
Roumpou A, Palermo A, Tournis S,
Hasenmajer V, Pasieka JL, Kaltsas G, Isidori A and Kassi E: Bone in
parathyroid diseases revisited: Evidence from epidemiological,
surgical and new drug outcomes. Endocr Rev. 46:576–620.
2025.PubMed/NCBI View Article : Google Scholar
|
|
112
|
Li M, Cheng J, Zhao J, Xue W, Bao H, Song
Y and Qin L: Relationship between intact parathyroid hormone and
all-cause death, cardiovascular events, and ectopic calcification
in patients with diabetic kidney disease: A retrospective study.
Diabetes Res Clin Pract. 177(108926)2021.PubMed/NCBI View Article : Google Scholar
|
|
113
|
Song L: Effects of exercise or mechanical
stimulation on bone development and bone repair. Stem Cells Int.
2022(5372229)2022.PubMed/NCBI View Article : Google Scholar
|
|
114
|
Tan H, Xu W, Ding X, Ye H, Hu Y, He X,
Ming Y and Zheng L: Notch/NICD/RBP-J signaling axis regulates M1
polarization of macrophages mediated by advanced glycation end
products. Glycoconj J. 39:487–497. 2022.PubMed/NCBI View Article : Google Scholar
|
|
115
|
Laohajaroensombat O, Poochanasri M and
Samakkarnthai P: An update on bone in diabetes. Curr Opin
Endocrinol Diabetes Obes. 32:142–148. 2025.PubMed/NCBI View Article : Google Scholar
|
|
116
|
Delgado-Calle J, Sato AY and Bellido T:
Role and mechanism of action of sclerostin in bone. Bone. 96:29–37.
2017.PubMed/NCBI View Article : Google Scholar
|
|
117
|
Wei J, Shimazu J, Makinistoglu MP, Maurizi
A, Kajimura D, Zong H, Takarada T, Lezaki T, Pessin JE, Hinoi E and
Karsenty G: Glucose uptake and Runx2 synergize to orchestrate
osteoblast differentiation and bone formation. Cell. 161:1576–1591.
2015.PubMed/NCBI View Article : Google Scholar
|
|
118
|
Farr JN, Drake MT, Amin S, Melton LJ III,
McCready LK and Khosla S: In vivo assessment of bone quality in
postmenopausal women with type 2 diabetes. J Bone Miner Res.
29:787–795. 2014.PubMed/NCBI View Article : Google Scholar
|
|
119
|
Zhai Z, Chen W, Hu Q, Wang X, Zhao Q and
Tuerxunyiming M: High glucose inhibits osteogenic differentiation
of bone marrow mesenchymal stem cells via regulating
miR-493-5p/ZEB2 signalling. J Biochem. 167:613–621. 2020.PubMed/NCBI View Article : Google Scholar
|
|
120
|
Lv J, Wang Q, Liu D, Chu CH, Zhou H, Li G,
Wu J, Cai K and Tang C: Calcium phytate reverses high
glucose-inhibited osteogenesis of BMSCs via the MAPK/JNK pathway.
Oral Dis. 30:1379–1391. 2024.PubMed/NCBI View Article : Google Scholar
|
|
121
|
Phadnis SM, Ghaskadbi SM, Hardikar AA and
Bhonde RR: Mesenchymal stem cells derived from bone marrow of
diabetic patients portrait unique markers influenced by the
diabetic microenvironment. Rev Diabet Stud. 6:260–270.
2009.PubMed/NCBI View Article : Google Scholar
|
|
122
|
Weffort D, Adolpho LF, Souza ATP, Freitas
GP, Lopes HB, Oliveira FS, Bighetti-Trevisan RL, Pitol-Palin L,
Matsushita DH, Okamoto R, et al: Normoglycemia partially recovers
the disrupted osteoblast differentiation of mesenchymal stem cells
induced by type 1 but not type 2 diabetes mellitus. J Cell Biochem.
124:1050–1063. 2023.PubMed/NCBI View Article : Google Scholar
|
|
123
|
Fu T, Zhu Q, Lou F, Cai S, Peng S and Xiao
J: Advanced glycation end products inhibit the osteogenic
differentiation potential of adipose-derived stem cells in mice
through autophagy. Cell Signal. 108(110694)2023.PubMed/NCBI View Article : Google Scholar
|
|
124
|
Zhao M, Rong R, Zhang C, Yang H, Han X,
Fan Z, Zheng Y and Zhang J: FBLN5 was regulated by PRDM9, and
promoted senescence and osteogenic differentiation of human
periodontal ligament stem cells. Curr Stem Cell Res Ther.
19:417–425. 2024.PubMed/NCBI View Article : Google Scholar
|
|
125
|
Guo J, Chen Z, Xiao Y, Yu G and Li Y:
SATB1 promotes osteogenic differentiation of diabetic rat BMSCs
through MAPK signalling activation. Oral Dis. 29:3610–3619.
2023.PubMed/NCBI View Article : Google Scholar
|
|
126
|
Sharma DK, Bahnisch R, Schultz CG, Rogers
M, Furst C, Solomon LB, Callary SA and Ramasamy B: Higher
carboxylated osteocalcin is an independent predictor of improved
femoral bone strength: A cross-sectional study. Bone.
200(117610)2025.PubMed/NCBI View Article : Google Scholar
|
|
127
|
Xu Y, Shen L, Liu L, Zhang Z and Hu W:
Undercarboxylated osteocalcin and its associations with bone
mineral density, bone turnover markers, and prevalence of
osteopenia and osteoporosis in Chinese population: A
cross-sectional study. Front Endocrinol (Lausanne).
13(843912)2022.PubMed/NCBI View Article : Google Scholar
|
|
128
|
Bernhard M, Okorie O, Tseng WJ, Chen M,
Danon J, Cui M, Lashbrooks E, Yang Y and Wang B: Metabolic shifts
in ratio of ucOcn to cOcn toward bone resorption contribute to
age-dependent bone loss in male mice. Am J Physiol Endocrinol
Metab. 327:E711–E722. 2024.PubMed/NCBI View Article : Google Scholar
|
|
129
|
Gao J, Bai T, Ren L, Ding Y, Zhong X, Wang
H, Guo Y, Li J, Liu Y and Zhang Y: The PLC/PKC/Ras/MEK/Kv channel
pathway is involved in uncarboxylated osteocalcin-regulated insulin
secretion in rats. Peptides. 86:72–79. 2016.PubMed/NCBI View Article : Google Scholar
|
|
130
|
Wang P, Zhang Y, Shan R, Wu J, Man S, Deng
Y, Lv J, Wang X, Yin J, Ning Y, et al: Association between
trajectories of fasting plasma glucose and risk of osteoporosis in
non-diabetic and diabetic populations. Front Public Health.
10(960928)2022.PubMed/NCBI View Article : Google Scholar
|
|
131
|
Bassi MM, Halawani IR, Alshehri HA,
Alyahya FS, Alhindi MY, Alamri RA, Alamri MA and Altuwairqi AA:
Prevalence of osteoporosis and osteopenia in patients with type 2
diabetes at King Abdulaziz University Hospital: A retrospective
analysis. Cureus. 17(e77624)2025.PubMed/NCBI View Article : Google Scholar
|
|
132
|
Lademann F, Rauner M, Bonnet N, Hofbauer
LC and Tsourdi E: Low bone turnover due to hypothyroidism or
anti-resorptive treatment does not affect whole-body glucose
homeostasis in male mice. J Pers Med. 12(1462)2022.PubMed/NCBI View Article : Google Scholar
|
|
133
|
Ferron M, McKee MD, Levine RL, Ducy P and
Karsenty G: Intermittent injections of osteocalcin improve glucose
metabolism and prevent type 2 diabetes in mice. Bone. 50:568–575.
2012.PubMed/NCBI View Article : Google Scholar
|
|
134
|
Zhang XL, Wang YN, Ma LY, Liu ZS, Ye F and
Yang JH: Uncarboxylated osteocalcin ameliorates hepatic glucose and
lipid metabolism in KKAy mice via activating insulin signaling
pathway. Acta Pharmacol Sin. 41:383–393. 2020.PubMed/NCBI View Article : Google Scholar
|
|
135
|
Ferron M, Wei J, Yoshizawa T, Del Fattore
A, DePinho RA, Teti A, Ducy P and Karsenty G: Insulin signaling in
osteoblasts integrates bone remodeling and energy metabolism. Cell.
142:296–308. 2010.PubMed/NCBI View Article : Google Scholar
|
|
136
|
Liu JM, Rosen CJ, Ducy P, Kousteni S and
Karsenty G: Regulation of glucose handling by the skeleton:
Insights from mouse and human studies. Diabetes. 65:3225–3232.
2016.PubMed/NCBI View Article : Google Scholar
|
|
137
|
Lacombe J, Karsenty G and Ferron M: In
vivo analysis of the contribution of bone resorption to the control
of glucose metabolism in mice. Mol Metab. 2:498–504.
2013.PubMed/NCBI View Article : Google Scholar
|
|
138
|
Li Q, Liu W, Zhang Y, Jin J, Ji P, Yuan Z,
Zhang Y, Feng P, Wu Y, Shen H and Wang P: ALG5 downregulation
inhibits osteogenesis and promotes adipogenesis by regulating the
N-glycosylation of SLC6A9 in osteoporosis. Cell Mol Life Sci.
82(35)2025.PubMed/NCBI View Article : Google Scholar
|
|
139
|
Feng P, Pang P, Sun Z, Xie Z, Chen T, Wang
S, Cao Q, Mi R, Zeng C, Lu Y, et al: Enhancer-mediated FOXO3
expression promotes MSC adipogenic differentiation by activating
autophagy. Biochim Biophys Acta Mol Basis Dis.
1870(166975)2024.PubMed/NCBI View Article : Google Scholar
|
|
140
|
Almeida M, Kim HN, Han L, Zhou D,
Thostenson J, Porter RM, Ambrogini E, Manolagas SC and Jilka RL:
Increased marrow adipogenesis does not contribute to age-dependent
appendicular bone loss in female mice. Aging Cell.
19(e13247)2020.PubMed/NCBI View Article : Google Scholar
|
|
141
|
Zhang J, Wang E, Li Q, Peng Y, Jin H,
Naseem S, Sun B, Park S, Choi S and Li X: GSK3 regulation
Wnt/β-catenin signaling affects adipogenesis in bovine skeletal
muscle fibro/adipogenic progenitors. Int J Biol Macromol.
275(133639)2024.PubMed/NCBI View Article : Google Scholar
|
|
142
|
Lim J, Kim HI, Bang Y and Choi HJ:
Peroxisome proliferator-activated receptor gamma: A novel
therapeutic target for cognitive impairment and mood disorders that
functions via the regulation of adult neurogenesis. Arch Pharm Res.
44:553–563. 2021.PubMed/NCBI View Article : Google Scholar
|
|
143
|
Xu Y, Jiang Y, Wang Y, Jia B, Gao S, Yu H,
Zhang H, Lv C, Li H and Li T: LINC00473-modified bone marrow
mesenchymal stem cells incorporated thermosensitive PLGA hydrogel
transplantation for steroid-induced osteonecrosis of femoral head:
A detailed mechanistic study and validity evaluation. Bioeng Transl
Med. 7(e10275)2022.PubMed/NCBI View Article : Google Scholar
|
|
144
|
Al Zein M, Zein O, Diab R, Dimachkie L,
Sahebkar A, Al-Asmakh M, Kobeissy F and Eid AH: Intermittent
fasting favorably modulates adipokines and potentially attenuates
atherosclerosis. Biochem Pharmacol. 218(115876)2023.PubMed/NCBI View Article : Google Scholar
|
|
145
|
Wu J, Hu M, Jiang H, Ma J, Xie C, Zhang Z,
Zhou X, Zhao J, Tao Z, Meng Y, et al: Endothelial cell-derived
lactate triggers bone mesenchymal stem cell histone lactylation to
attenuate osteoporosis. Adv Sci (Weinh).
10(e2301300)2023.PubMed/NCBI View Article : Google Scholar
|
|
146
|
Tang B, Chen Y, Zhao P, Yan W, Huang X,
Jiang W, Sun M, Zhang H, Xiang D, Chen T, et al: MiR-601-induced
BMSCs senescence accelerates steroid-induced osteonecrosis of the
femoral head progression by targeting SIRT1. Cell Mol Life Sci.
80(261)2023.PubMed/NCBI View Article : Google Scholar
|
|
147
|
Ma X and Zhang X: Research progress of
diabetic osteoporosis: A comprehensive review. Front Endocrinol
(Lausanne). 16(1595228)2025.PubMed/NCBI View Article : Google Scholar
|
|
148
|
Zhong Y, Yang S, Li S, Yuan S, Chen X,
Long H, Wu H, Guo Y and Wang T: IL-27 alleviates high-fat
diet-induced obesity and metabolic disorders by inhibiting
adipogenesis via activating HDAC6. Commun Biol.
8(460)2025.PubMed/NCBI View Article : Google Scholar
|
|
149
|
Rial SA, Shishani R, Cummings BP and Lim
GE: Is 14-3-3 the combination to unlock new pathways to improve
metabolic homeostasis and β-cell function? Diabetes. 72:1045–1054.
2023.PubMed/NCBI View Article : Google Scholar
|
|
150
|
Yang H, Kabin E, Dong Y, Zhang X, Ralle M
and Lutsenko S: ATP7A-dependent copper sequestration contributes to
termination of β-CATENIN signaling during early adipogenesis. Mol
Metab. 80(101872)2024.PubMed/NCBI View Article : Google Scholar
|
|
151
|
Upadhyay P and Kumar S: Diabetes and bone
health: A comprehensive review of impacts and mechanisms. Diabetes
Metab Res Rev. 41(e70062)2025.PubMed/NCBI View Article : Google Scholar
|
|
152
|
Huang H, Xiao T, Li Y, Ning C, Tan G and
Zhou L: Adaptive smart hydrogels driving precision bone healing in
pathological contexts. J Control Release.
391(114617)2026.PubMed/NCBI View Article : Google Scholar
|
|
153
|
Jiang N, Liu J, Guan C, Ma C, An J and
Tang X: Thioredoxin-interacting protein: A new therapeutic target
in bone metabolism disorders? Front Immunol.
13(955128)2022.PubMed/NCBI View Article : Google Scholar
|
|
154
|
Lv L, Wang T, Xie W, Wei J, Zhou L, Qiu X,
Feng H and Gu W: Revealing VNN1: An emerging and promising target
for inflammation and redox balance. Immun Inflamm Dis.
13(e70274)2025.PubMed/NCBI View Article : Google Scholar
|
|
155
|
Mohammad OH, Yang S, Ji W, Ma H and Tao R:
Curcumin preserves bone health compromised by diabetes by
inhibiting osteoporosis through regulation of the SIRT3/FoxO3a
signalling pathway. Sci Rep. 15(29566)2025.PubMed/NCBI View Article : Google Scholar
|
|
156
|
Alhawiti NM, Al Mahri S, Aziz MA, Malik SS
and Mohammad S: TXNIP in metabolic regulation: Physiological role
and therapeutic outlook. Curr Drug Targets. 18:1095–1103.
2017.PubMed/NCBI View Article : Google Scholar
|
|
157
|
Cao X, Liu K, Yuan J, Hua Q, Rong K, Zhou
T, He W, Pang Y, Yang X, Yu Y, et al: Transcriptional regulation of
Rankl by Txnip-Ecd in aging and diabetic related osteoporosis. J
Adv Res. 77:221–234. 2025.PubMed/NCBI View Article : Google Scholar
|
|
158
|
Wondafrash DZ, Nire'a AT, Tafere GG, Desta
DM, Berhe DA and Zewdie KA: Thioredoxin-interacting protein as a
novel potential therapeutic target in diabetes mellitus and its
underlying complications. Diabetes Metab Syndr Obes. 13:43–51.
2020.PubMed/NCBI View Article : Google Scholar
|
|
159
|
Yu H, Cui Y, Guo F, Zhu Y, Zhang X, Shang
D, Dong D and Xiang H: Vanin1 (VNN1) in chronic diseases: Future
directions for targeted therapy. Eur J Pharmacol.
962(176220)2024.PubMed/NCBI View Article : Google Scholar
|
|
160
|
Naquet P, Pitari G, Duprè S and Galland F:
Role of the Vnn1 pantetheinase in tissue tolerance to stress.
Biochem Soc Trans. 42:1094–1100. 2014.PubMed/NCBI View Article : Google Scholar
|
|
161
|
Millet V, Gensollen T, Maltese M, Serrero
M, Lesavre N, Bourges C, Pitaval C, Cadra S, Chasson L, Vu Man TP,
et al: Harnessing the Vnn1 pantetheinase pathway boosts short chain
fatty acids production and mucosal protection in colitis. Gut.
72:1115–1128. 2023.PubMed/NCBI View Article : Google Scholar
|
|
162
|
Qin W, Kang M, Li C, Zheng W and Guo Q:
VNN1 overexpression in pancreatic cancer cells inhibits
paraneoplastic islet function by increasing oxidative stress and
inducing β-cell dedifferentiation. Oncol Rep.
49(120)2023.PubMed/NCBI View Article : Google Scholar
|
|
163
|
van Diepen JA, Jansen PA, Ballak DB,
Hijmans A, Rutjes FP, Tack CJ, Netea MG, Schalkwijk J and Stienstra
R: Genetic and pharmacological inhibition of vanin-1 activity in
animal models of type 2 diabetes. Sci Rep. 6(21906)2016.PubMed/NCBI View Article : Google Scholar
|
|
164
|
Li F, Wang Y, Cao J, Chen Q, Gao Y, Li R
and Yuan L: Integrated analysis of genes shared between type 2
diabetes mellitus and osteoporosis. Front Pharmacol.
15(1388205)2024.PubMed/NCBI View Article : Google Scholar
|
|
165
|
Berruyer C, Pouyet L, Millet V, Martin FM,
LeGoffic A, Canonici A, Garcia S, Bagnis C, Naquet P and Galland F:
Vanin-1 licenses inflammatory mediator production by gut epithelial
cells and controls colitis by antagonizing peroxisome
proliferator-activated receptor gamma activity. J Exp Med.
203:2817–2827. 2006.PubMed/NCBI View Article : Google Scholar
|
|
166
|
Chen S, Zhang W, Tang C, Tang X, Liu L and
Liu C: Vanin-1 is a key activator for hepatic gluconeogenesis.
Diabetes. 63:2073–2085. 2014.PubMed/NCBI View Article : Google Scholar
|
|
167
|
Cheng W, Xu X, Lang Y, Cheng Z, Rizwan M,
Tang X, Xie L and Liu Y, Xu H and Liu Y: Anatase and rutile
TiO2 nanoparticles lead effective bone damage in young
rat model via the IGF-1 signaling pathway. Int J Nanomedicine.
16:7233–7247. 2021.PubMed/NCBI View Article : Google Scholar
|
|
168
|
Kakoki M, Ramanathan PV, Hagaman JR, Grant
R, Wilder JC, Taylor JM, Charles Jennette J, Smithies O and
Maeda-Smithies N: Cyanocobalamin prevents cardiomyopathy in type 1
diabetes by modulating oxidative stress and DNMT-SOCS1/3-IGF-1
signaling. Commun Biol. 4(775)2021.PubMed/NCBI View Article : Google Scholar
|
|
169
|
Ling W, Krager K, Richardson KK, Warren
AD, Ponte F, Aykin-Burns N, Manolagas SC, Almeida M and Kim HN:
Mitochondrial Sirt3 contributes to the bone loss caused by aging or
estrogen deficiency. JCI Insight. 6(e146728)2021.PubMed/NCBI View Article : Google Scholar
|
|
170
|
Li G, Jian Z, Wang H, Xu L, Zhang T and
Song J: Irisin promotes osteogenesis by modulating oxidative stress
and mitophagy through SIRT3 signaling under diabetic conditions.
Oxid Med Cell Longev. 2022(3319056)2022.PubMed/NCBI View Article : Google Scholar
|
|
171
|
Huang X, Shu H, Ren C and Zhu J: SIRT3
improves bone regeneration and rescues diabetic fracture healing by
regulating oxidative stress. Biochem Biophys Res Commun.
604:109–115. 2022.PubMed/NCBI View Article : Google Scholar
|
|
172
|
Ebrahimi R, Mohammadpour A, Medoro A,
Davinelli S, Saso L and Miroliaei M: Exploring the links between
polyphenols, Nrf2, and diabetes: A review. Biomed Pharmacother.
186(118020)2025.PubMed/NCBI View Article : Google Scholar
|
|
173
|
Baumel-Alterzon S, Katz LS, Brill G,
Garcia-Ocaña A and Scott DK: Nrf2: The master and captain of beta
cell fate. Trends Endocrinol Metab. 32:7–19. 2021.PubMed/NCBI View Article : Google Scholar
|
|
174
|
Zhao S, Lo CS, Miyata KN, Ghosh A, Zhao
XP, Chenier I, Cailhier JF, Ethier J, Lattouf JB, Filep JG, et al:
Overexpression of Nrf2 in renal proximal tubular cells stimulates
sodium-glucose cotransporter 2 expression and exacerbates
dysglycemia and kidney injury in diabetic mice. Diabetes.
70:1388–1403. 2021.PubMed/NCBI View Article : Google Scholar
|
|
175
|
Si Y, Li Y, Gu K, Yin H and Ma Y: Icariin
ameliorates osteoporosis in ovariectomized rats by targeting Cullin
3/Nrf2/OH pathway for osteoclast inhibition. Biomed Pharmacother.
173(116422)2024.PubMed/NCBI View Article : Google Scholar
|
|
176
|
Gu HY, Liu N, Lin FX and Yin J: Nrf2
signaling pathway: Focus on oxidative stress in osteoporosis.
Osteoporos Int. 36:1837–1854. 2025.PubMed/NCBI View Article : Google Scholar
|
|
177
|
Wang T, Chen J, Qu B, Zhou D and Hong Z:
Scutellarin alleviates bone marrow mesenchymal stromal cellular
senescence via the Ezh2-Nrf2 signalling axis in diabetes-induced
bone loss. Cell Prolif. 58(e13790)2025.PubMed/NCBI View Article : Google Scholar
|
|
178
|
Cao Z, Niu X, Wang M, Yu S, Wang M, Mu S,
Liu C and Wang Y: Anemoside B4 attenuates RANKL-induced
osteoclastogenesis by upregulating Nrf2 and dampens
ovariectomy-induced bone loss. Biomed Pharmacother.
167(115454)2023.PubMed/NCBI View Article : Google Scholar
|
|
179
|
Wang YF, Chang YY, Zhang XM, Gao MT, Zhang
QL, Li X, Zhang L and Yao WF: Salidroside protects against
osteoporosis in ovariectomized rats by inhibiting oxidative stress
and promoting osteogenesis via Nrf2 activation. Phytomedicine.
99(154020)2022.PubMed/NCBI View Article : Google Scholar
|
|
180
|
Xu L, Zhu J, Rong L, Yang H, Wang B, Lu S,
Zhang L, Li F, Yang S, Wang Z, et al: Osteoblast-specific
down-regulation of NLRP3 inflammasome by aptamer-functionalized
liposome nanoparticles improves bone quality in postmenopausal
osteoporosis rats. Theranostics. 14:3945–3962. 2024.PubMed/NCBI View Article : Google Scholar
|
|
181
|
Ye J, Li L, Wang M, Ma Q, Tian Y, Zhang Q,
Liu J, Li B, Zhang B, Liu H and Sun G: Diabetes mellitus promotes
the development of atherosclerosis: The role of NLRP3. Front
Immunol. 13(900254)2022.PubMed/NCBI View Article : Google Scholar
|
|
182
|
Xing X, Gong Z, Chen C, Lin Y, Liu P, Xiao
T, Yu H, Li Y, Lin Y, Tan G, et al: Injectable bioresponsive bone
adhesive hydrogels inhibit NLRP3 inflammasome on demand to
accelerate diabetic fracture healing. Biomaterials.
317(123059)2025.PubMed/NCBI View Article : Google Scholar
|
|
183
|
Cai G, Song X, Luo H, Dai G, Zhang H,
Jiang D, Lei X, Chen H and Zhang L: NLRP3 blockade by MCC950
suppressed osteoclastogenesis via NF-κB/c-Fos/NFATc1 signal pathway
and alleviated bone loss in diabetes mellitus. Mol Cell Endocrinol.
594(112382)2024.PubMed/NCBI View Article : Google Scholar
|
|
184
|
Feng S, Ma R, Huang Y, Pan L, Guo Y, Wang
Y, Chen Z, Li E, Bu Y, Luo J, et al: Rosmarinic acid ameliorates
type 2 diabetic osteoporosis by reducing NLRP3 expression and
alleviating osteoblast pyroptosis via the FOXO1/TXNIP signaling
pathway. J Agric Food Chem. 73:16557–16572. 2025.PubMed/NCBI View Article : Google Scholar
|
|
185
|
Tang H, Du Y, Tan Z, Li D and Xie J:
METTL14-mediated HOXA5 m6A modification alleviates
osteoporosis via promoting WNK1 transcription to suppress
NLRP3-dependent macrophage pyroptosis. J Orthop Translat.
48:190–203. 2024.PubMed/NCBI View Article : Google Scholar
|
|
186
|
Hu S, Hu Y, Long P, Li P, Chen P and Wang
X: The effect of tai chi intervention on NLRP3 and its related
antiviral inflammatory factors in the serum of patients with
pre-diabetes. Front Immunol. 13(1026509)2022.PubMed/NCBI View Article : Google Scholar
|
|
187
|
Li Y, Yang JY, Lin ML, Liu TZ, Lu WN, Yang
Y, Liu ZC, Li JH, Zhang GQ and Guo JS: ACT001 improves OVX-induced
osteoporosis by suppressing the NF-κB/NLRP3 signaling pathway. Mol
Med. 31(131)2025.PubMed/NCBI View Article : Google Scholar
|
|
188
|
Sharma A, Choi JSY, Stefanovic N,
Al-Sharea A, Simpson DS, Mukhamedova N, Jandeleit-Dahm K, Murphy
AJ, Sviridov D, Vince JE, et al: Specific NLRP3 inhibition protects
against diabetes-associated atherosclerosis. Diabetes. 70:772–787.
2021.PubMed/NCBI View Article : Google Scholar
|
|
189
|
Sano T, Akeda K, Yamada J, Takegami N,
Sudo T and Sudo A: Expression of the RANK/RANKL/OPG system in the
human intervertebral disc: Implication for the pathogenesis of
intervertebral disc degeneration. BMC Musculoskelet Disord.
20(225)2019.PubMed/NCBI View Article : Google Scholar
|
|
190
|
Abe I, Ochi K, Takashi Y, Yamao Y, Ohishi
H, Fujii H, Minezaki M, Sugimoto K, Kudo T, Abe M, et al: Effect of
denosumab, a human monoclonal antibody of receptor activator of
nuclear factor kappa-B ligand (RANKL), upon glycemic and metabolic
parameters: Effect of denosumab on glycemic parameters. Medicine
(Baltimore). 98(e18067)2019.PubMed/NCBI View Article : Google Scholar
|
|
191
|
Lamothe B, Webster WK, Gopinathan A, Besse
A, Campos AD and Darnay BG: TRAF6 ubiquitin ligase is essential for
RANKL signaling and osteoclast differentiation. Biochem Biophys Res
Commun. 359:1044–1049. 2007.PubMed/NCBI View Article : Google Scholar
|
|
192
|
Marino S, Hannemann N, Bishop RT, Zeng F,
Carrasco G, Meurisse S, Li B, Sophocleous A, Sparatore A, Baeuerle
T, et al: Anti-inflammatory, but not osteoprotective, effect of the
TRAF6/CD40 inhibitor 6877002 in rodent models of local and systemic
osteolysis. Biochem Pharmacol. 195(114869)2022.PubMed/NCBI View Article : Google Scholar
|
|
193
|
Huang Y, Wu J, Zhan C, Liu R, Zhou Z,
Huang X, Tian Y, Lin Z and Song Z: TRAF-STOP alleviates
osteoclastogenesis in periodontitis. Front Pharmacol.
14(1119847)2023.PubMed/NCBI View Article : Google Scholar
|
|
194
|
Bishop RT, Marino S, Carrasco G, Li B,
Allen RJ, Sparatore A, Ottewell PD, Mollat P, Sims AH, Capulli M,
et al: Combined administration of a small-molecule inhibitor of
TRAF6 and Docetaxel reduces breast cancer skeletal metastasis and
osteolysis. Cancer Lett. 488:27–39. 2020.PubMed/NCBI View Article : Google Scholar
|
|
195
|
Wang H, Chen W, Wang L, Li F, Zhang C and
Xu L: Tumor necrosis factor receptor-associated factor 6 promotes
migration of rheumatoid arthritis fibroblast-like synoviocytes. Mol
Med Rep. 11:2761–2766. 2015.PubMed/NCBI View Article : Google Scholar
|
|
196
|
Kong R, Gao J, Ji L, Peng Y, Zhang J and
Zhao D: Iguratimod ameliorates rheumatoid arthritis progression
through regulating miR-146a mediated IRAK1 expression and
TRAF6/JNK1 pathway: An in vivo and in vitro study. Clin Exp
Rheumatol. 39:289–303. 2021.PubMed/NCBI View Article : Google Scholar
|
|
197
|
Brenke JK, Popowicz GM, Schorpp K,
Rothenaigner I, Roesner M, Meininger I, Kalinski C, Ringelstetter
L, R'kyek O, Jürjens G, et al: Targeting TRAF6 E3 ligase activity
with a small-molecule inhibitor combats autoimmunity. J Biol Chem.
293:13191–13203. 2018.PubMed/NCBI View Article : Google Scholar
|
|
198
|
Xu S, Li S, Liu X, Tan K, Zhang J, Li K,
Bai X and Zhang Y: Rictor is a novel regulator of TRAF6/TRAF3 in
osteoclasts. J Bone Miner Res. 36:2053–2064. 2021.PubMed/NCBI View Article : Google Scholar
|
|
199
|
Liu DM, Zhao L, Liu TT, Jiao PL, Zhao DD,
Shih MS, Tao B, Sun LH, Zhao HY and Liu JM: Rictor/mTORC2 loss in
osteoblasts impairs bone mass and strength. Bone. 90:50–58.
2016.PubMed/NCBI View Article : Google Scholar
|
|
200
|
Levi-D'Ancona E, Walker EM, Zhu J, Deng Y,
Sidarala V, Stendahl AM, Reck EC, Henry-Kanarek BA, Lietzke AC,
Chai B, et al: TRAF6 integrates innate immune signals to regulate
glucose homeostasis via Parkin-dependent and Parkin-independent
mitophagy. Sci Adv. 11(eadw4153)2025.PubMed/NCBI View Article : Google Scholar
|
|
201
|
Chatzigeorgiou A, Seijkens T, Zarzycka B,
Engel D, Poggi M, van den Berg S, van den Berg S, Soehnlein O,
Winkels H, Beckers L, et al: Blocking CD40-TRAF6 signaling is a
therapeutic target in obesity-associated insulin resistance. Proc
Natl Acad Sci USA. 111:2686–2691. 2014.PubMed/NCBI View Article : Google Scholar
|
|
202
|
Hu L, Liu H, Ma H, Zeng X, Cao Y, Liu B,
Li H and Zhang X: TRAF6-mediated ubiquitination of AKT1 in the
nucleus occurs in a β-arrestin2-dependent manner upon insulin
stimulation. Biochem Pharmacol. 226(116362)2024.PubMed/NCBI View Article : Google Scholar
|
|
203
|
Zhang Z, Wen H, Peng B, Weng J and Zeng F:
HFD-induced TRAF6 upregulation promotes liver cholesterol
accumulation and fatty liver development via EZH2-mediated
miR-429/PPARα axis. Mol Ther Nucleic Acids. 24:711–727.
2021.PubMed/NCBI View Article : Google Scholar
|
|
204
|
Zhang JL, Du BB, Zhang DH, Li H, Kong LY,
Fan GJ, Li YP, Li PC, Liang C, Wang Z, et al: OTUB1 alleviates NASH
through inhibition of the TRAF6-ASK1 signaling pathways.
Hepatology. 75:1218–1234. 2022.PubMed/NCBI View Article : Google Scholar
|
|
205
|
Feng Z, Du Z, Shu X, Zhu L, Wu J, Gao Q,
Wang L, Chen N, Li Y, Luo M, et al: Role of RAGE in obesity-induced
adipose tissue inflammation and insulin resistance. Cell Death
Discov. 7(305)2021.PubMed/NCBI View Article : Google Scholar
|
|
206
|
Hou L, Jiang F, Huang B, Zheng W, Jiang Y,
Cai G, Liu D, Hu CY and Wang C: Dihydromyricetin ameliorates
inflammation-induced insulin resistance via phospholipase
C-CaMKK-AMPK signal pathway. Oxid Med Cell Longev.
2021(8542809)2021.PubMed/NCBI View Article : Google Scholar
|
|
207
|
Zhou M, Zhang Y, Shi L, Li L, Zhang D,
Gong Z and Wu Q: Activation and modulation of the AGEs-RAGE axis:
Implications for inflammatory pathologies and therapeutic
interventions-a review. Pharmacol Res. 206(107282)2024.PubMed/NCBI View Article : Google Scholar
|
|
208
|
Shen CY, Lu CH, Wu CH, Li KJ, Kuo YM,
Hsieh SC and Yu CL: The development of maillard reaction, and
advanced glycation end product (AGE)-receptor for AGE (RAGE)
signaling inhibitors as novel therapeutic strategies for patients
with AGE-related diseases. Molecules. 25(5591)2020.PubMed/NCBI View Article : Google Scholar
|
|
209
|
Zaki MK, Abed MN and Alassaf FA:
Antidiabetic agents and bone quality: A focus on glycation end
products and incretin pathway modulations. J Bone Metab.
31:169–181. 2024.PubMed/NCBI View Article : Google Scholar
|
|
210
|
Tolosa MJ, Chuguransky SR, Sedlinsky C,
Schurman L, McCarthy AD, Molinuevo MS and Cortizo AM:
Insulin-deficient diabetes-induced bone microarchitecture
alterations are associated with a decrease in the osteogenic
potential of bone marrow progenitor cells: Preventive effects of
metformin. Diabetes Res Clin Pract. 101:177–186. 2013.PubMed/NCBI View Article : Google Scholar
|
|
211
|
Gao Q, Jiang Y, Zhou D, Li G, Han Y, Yang
J, Xu K, Jing Y, Bai L, Geng Z, et al: Advanced glycation end
products mediate biomineralization disorder in diabetic bone
disease. Cell Rep Med. 5(101694)2024.PubMed/NCBI View Article : Google Scholar
|
|
212
|
Tanabe N, Tomita K, Manaka S, Ichikawa R,
Takayama T, Kawato T, Ono M, Masai Y, Utsu A, Suzuki N and Sato S:
Co-stimulation of AGEs and LPS induces inflammatory mediators
through PLCγ1/JNK/NF-κB pathway in MC3T3-E1 cells. Cells.
12(1383)2023.PubMed/NCBI View Article : Google Scholar
|
|
213
|
Ghaffar S, Waraich RS, Orfali R, Al-Taweel
A, Aati HY, Kamran S and Perveen S: New glycotoxin inhibitor from
sesuvium sesuvioides mitigates symptoms of insulin resistance and
diabetes by suppressing AGE-RAGE axis in skeletal muscle.
Molecules. 29(3649)2024.PubMed/NCBI View Article : Google Scholar
|
|
214
|
He Y, Zhou C, Huang M, Tang C, Liu X, Yue
Y, Diao Q, Zheng Z and Liu D: Glyoxalase system: A systematic
review of its biological activity, related-diseases, screening
methods and small molecule regulators. Biomed Pharmacother.
131(110663)2020.PubMed/NCBI View Article : Google Scholar
|
|
215
|
Xu K, Zhang L, Yu N, Ren Z, Wang T, Zhang
Y, Zhao X and Yu T: Effects of advanced glycation end products
(AGEs) on the differentiation potential of primary stem cells: A
systematic review. Stem Cell Res Ther. 14(74)2023.PubMed/NCBI View Article : Google Scholar
|
|
216
|
Sun Y, Zhu Y, Liu X, Chai Y and Xu J:
Morroniside attenuates high glucose-induced BMSC dysfunction by
regulating the Glo1/AGE/RAGE axis. Cell Prolif.
53(e12866)2020.PubMed/NCBI View Article : Google Scholar
|
|
217
|
Cely I, Blencowe M, Shu L, Diamante G, Ahn
IS, Zhang G, LaGuardia J, Liu R, Saleem Z, Wang S, et al: Glo1
reduction in mice results in age- and sex-dependent metabolic
dysfunction. bioRxiv [Preprint]: 2025.01.24.634754, 2025.
|
|
218
|
Libro R, Bramanti P and Mazzon E: The role
of the Wnt canonical signaling in neurodegenerative diseases. Life
Sci. 158:78–88. 2016.PubMed/NCBI View Article : Google Scholar
|
|
219
|
Kim I, Park S, Kim J, Park SY, Seo J and
Roh S: Treatment with Lactobacillus paracasei L30 extract
induces osteogenic differentiation of human bone marrow mesenchymal
stem cells in vitro. Biomed Pharmacother.
184(117913)2025.PubMed/NCBI View Article : Google Scholar
|
|
220
|
Marcella BM, Hockey BL, Braun JL, Whitley
KC, Geromella MS, Baranowski RW, Watson CJF, Silvera S, Hamstra SI,
Wasilewicz LJ, et al: GSK3 inhibition improves skeletal muscle
function and whole-body metabolism in male mouse models of Duchenne
muscular dystrophy. Nat Commun. 15(10210)2024.PubMed/NCBI View Article : Google Scholar
|
|
221
|
Comeau-Gauthier M, Tarchala M, Luna JLR,
Harvey E and Merle G: Unleashing β-catenin with a new
anti-Alzheimer drug for bone tissue regeneration. Injury.
51:2449–2459. 2020.PubMed/NCBI View Article : Google Scholar
|
|
222
|
Bao K, Jiao Y, Xing L, Zhang F and Tian F:
The role of wnt signaling in diabetes-induced osteoporosis.
Diabetol Metab Syndr. 15(84)2023.PubMed/NCBI View Article : Google Scholar
|
|
223
|
Zhang M, Li Y, Rao P, Huang K, Luo D, Cai
X and Xiao J: Blockade of receptors of advanced glycation end
products ameliorates diabetic osteogenesis of adipose-derived stem
cells through DNA methylation and Wnt signalling pathway. Cell
Prolif. 51(e12471)2018.PubMed/NCBI View Article : Google Scholar
|
|
224
|
Leanza G, Cannata F, Faraj M, edone C,
Viola V, Tramontana F, Pellegrini N, Vadalà G, Piccoli A, Strollo
R, et al: Bone canonical Wnt signaling is downregulated in type 2
diabetes and associates with higher advanced glycation end-products
(AGEs) content and reduced bone strength. Elife.
12(RP90437)2024.PubMed/NCBI View Article : Google Scholar
|
|
225
|
Yu L, Xie M, Zhang F, Wan C and Yao X:
TM9SF4 is a novel regulator in lineage commitment of bone marrow
mesenchymal stem cells to either osteoblasts or adipocytes. Stem
Cell Res Ther. 12(573)2021.PubMed/NCBI View Article : Google Scholar
|
|
226
|
He D, Liu H, Wei W, Zhao Y, Cai Q, Shi S,
Chu X, Qin X, Zhang N, Xu P and Zhang F: A longitudinal genome-wide
association study of bone mineral density mean and variability in
the UK Biobank. Osteoporos Int. 34:1907–1916. 2023.PubMed/NCBI View Article : Google Scholar
|
|
227
|
Mori K, Suzuki K, Hozumi A, Goto H, Tomita
M, Koseki H, Yamashita S and Osaki M: Potentiation of
osteoclastogenesis by adipogenic conversion of bone marrow-derived
mesenchymal stem cells. Biomed Res. 35:153–159. 2014.PubMed/NCBI View Article : Google Scholar
|
|
228
|
Esen E, Chen J, Karner CM, Okunade AL,
Patterson BW and Long F: WNT-LRP5 signaling induces Warburg effect
through mTORC2 activation during osteoblast differentiation. Cell
Metab. 17:745–755. 2013.PubMed/NCBI View Article : Google Scholar
|
|
229
|
Elghazi L, Gould AP, Weiss AJ, Barker DJ,
Callaghan J, Opland D, Myers M, Cras-Méneur C and Bernal-Mizrachi
E: Importance of β-catenin in glucose and energy homeostasis. Sci
Rep. 2(693)2012.PubMed/NCBI View Article : Google Scholar
|
|
230
|
Napoli N, Chandran M, Pierroz DD,
Abrahamsen B, Schwartz AV and Ferrari SL: IOF Bone and Diabetes
Working Group. Mechanisms of diabetes mellitus-induced bone
fragility. Nat Rev Endocrinol. 13:208–219. 2017.PubMed/NCBI View Article : Google Scholar
|
|
231
|
Sheng N, Xing F, Wang J, Zhang QY, Nie R,
Li-Ling J, Duan X and Xie HQ: Recent progress in bone-repair
strategies in diabetic conditions. Mater Today Bio.
23(100835)2023.PubMed/NCBI View Article : Google Scholar
|
|
232
|
Cavati G, Pirrotta F, Merlotti D,
Ceccarelli E, Calabrese M, Gennari L and Mingiano C: Role of
advanced glycation end-products and oxidative stress in
type-2-diabetes-induced bone fragility and implications on fracture
risk stratification. Antioxidants (Basel). 12(928)2023.PubMed/NCBI View Article : Google Scholar
|
|
233
|
Karsenty G and Ferron M: The contribution
of bone to whole-organism physiology. Nature. 481:314–320.
2012.PubMed/NCBI View Article : Google Scholar
|
|
234
|
Al Rifai O, Julien C, Lacombe J, Faubert
D, Lira-Navarrete E, Narimatsu Y, Clausen H and Ferron M: The
half-life of the bone-derived hormone osteocalcin is regulated
through O-glycosylation in mice, but not in humans. Elife.
9(e61174)2020.PubMed/NCBI View Article : Google Scholar
|
|
235
|
Zhao Y, Yao H, Liao Y, Jiang B, Li T, Chen
J, Sheng Y, Yin M, Ye W, Yan Q and Ji Y: Selective PPARγ modulator
alpinetin restores insulin sensitivity and protects from bone loss
in type 2 diabetes. Phytomedicine. 145(157003)2025.PubMed/NCBI View Article : Google Scholar
|
|
236
|
Liu J, Li X, Wang H, Ren Y, Li Y and Guo
F: Bavachinin selectively modulates PPAR γ and maintains bone
homeostasis in type 2 diabetes. Phytother Res. 37:4457–4472.
2023.PubMed/NCBI View Article : Google Scholar
|
|
237
|
Yakar S, Rosen CJ, Bouxsein ML, Sun H,
Mejia W, Kawashima Y, Wu Y, Emerton K, Williams V, Jepsen K, et al:
Serum complexes of insulin-like growth factor-1 modulate skeletal
integrity and carbohydrate metabolism. FASEB J. 23:709–719.
2009.PubMed/NCBI View Article : Google Scholar
|
|
238
|
Zheng L, Shen X, Xie Y, Lian H, Yan S and
Wang S: Metformin promotes osteogenic differentiation and prevents
hyperglycaemia-induced osteoporosis by suppressing PPARγ
expression. Acta Biochim Biophys Sin (Shanghai). 55:394–403.
2023.PubMed/NCBI View Article : Google Scholar
|
|
239
|
Li ZW, Piao CD, Sun HH, Ren XS and Bai YS:
Asiatic acid inhibits adipogenic differentiation of bone marrow
stromal cells. Cell Biochem Biophys. 68:437–442. 2014.PubMed/NCBI View Article : Google Scholar
|
|
240
|
Farrell M, Fairfield H, Costa S, D'Amico
A, Falank C, Brooks DJ and Reagan MR: Sclerostin-neutralizing
antibody treatment rescues negative effects of rosiglitazone on
mouse bone parameters. J Bone Miner Res. 36:158–169.
2021.PubMed/NCBI View Article : Google Scholar
|
|
241
|
Ruan X, Jin X, Sun F, Pi J, Jinghu Y, Lin
X, Zhang N and Chen G: IGF signaling pathway in bone and cartilage
development, homeostasis, and disease. FASEB J.
38(e70031)2024.PubMed/NCBI View Article : Google Scholar
|
|
242
|
Werner H, Weinstein D and Bentov I:
Similarities and differences between insulin and IGF-I: Structures,
receptors, and signalling pathways. Arch Physiol Biochem.
114:17–22. 2008.PubMed/NCBI View Article : Google Scholar
|
|
243
|
Chen G, Fan XY, Zheng XP, Jin YL, Liu Y
and Liu SC: Human umbilical cord-derived mesenchymal stem cells
ameliorate insulin resistance via PTEN-mediated crosstalk between
the PI3K/Akt and Erk/MAPKs signaling pathways in the skeletal
muscles of db/db mice. Stem Cell Res Ther. 11(401)2020.PubMed/NCBI View Article : Google Scholar
|
|
244
|
Wei W and Wan Y: Thiazolidinediones on
PPARγ: The roles in bone remodeling. PPAR Res.
2011(867180)2011.PubMed/NCBI View Article : Google Scholar
|
|
245
|
Celik B, Leal AF and Tomatsu S: Potential
targeting mechanisms for bone-directed therapies. Int J Mol Sci.
25(8339)2024.PubMed/NCBI View Article : Google Scholar
|
|
246
|
Chen Y, Wu X, Li J, Jiang Y, Xu K and Su
J: Bone-targeted nanoparticle drug delivery system: An emerging
strategy for bone-related disease. Front Pharmacol.
13(909408)2022.PubMed/NCBI View Article : Google Scholar
|
|
247
|
Cui Y, Lv B, Li Z, Ma C, Gui Z, Geng Y,
Liu G, Sang L, Xu C, Min Q, et al: Bone-targeted biomimetic
nanogels re-establish osteoblast/osteoclast balance to treat
postmenopausal osteoporosis. Small. 20(e2303494)2024.PubMed/NCBI View Article : Google Scholar
|
|
248
|
Ahmad Hairi H, Mustafa NH, Shuid AN and
Sadikan MZ: In vivo models of diabetes: Unravelling molecular
pathways in metabolic and skeletal complications. Biomedicines.
14(243)2026.PubMed/NCBI View Article : Google Scholar
|
|
249
|
Khashayar P, Rad FF, Tabatabaei-Malazy O,
Golabchi SM, Khashayar P, Mohammadi M, Ebrahimpour S and Larijani
B: Hypoglycemic agents and bone health; an umbrella systematic
review of the clinical trials' meta-analysis studies. Diabetol
Metab Syndr. 16(310)2024.PubMed/NCBI View Article : Google Scholar
|
|
250
|
Wang YB, Li ZP, Wang P, Wang RB, Ruan YH,
Shi Z, Li HY, Sun JK, Mi Y, Li CJ, et al: Iron dysregulation,
ferroptosis, and oxidative stress in diabetic osteoporosis:
Mechanisms, bone metabolism disruption, and therapeutic strategies.
World J Diabetes. 16(106720)2025.PubMed/NCBI View Article : Google Scholar
|
|
251
|
Du A, Xu R, Yang Q, Lu Y and Luo X:
Exploration of shared gene signatures and molecular mechanisms
between type 2 diabetes and osteoporosis. J Cell Mol Med.
28(e18141)2024.PubMed/NCBI View Article : Google Scholar
|
|
252
|
Lin HH, Hsu HY, Tsai MC, Hsu LY, Chien KL
and Yeh TL: Association between type 2 diabetes and osteoporosis
risk: A representative cohort study in Taiwan. PLoS One.
16(e0254451)2021.PubMed/NCBI View Article : Google Scholar
|
|
253
|
Brandt IAG, Starup-Linde J, Andersen SS
and Viggers R: Diagnosing osteoporosis in diabetes-a systematic
review on BMD and fractures. Curr Osteoporos Rep. 22:223–244.
2024.PubMed/NCBI View Article : Google Scholar
|
|
254
|
Emerzian SR, Johannesdottir F, Yu EW and
Bouxsein ML: Use of noninvasive imaging to identify causes of
skeletal fragility in adults with diabetes: A review. JBMR Plus.
8(ziae003)2024.PubMed/NCBI View Article : Google Scholar
|
|
255
|
Fan ST, Lu M, Dong JL, Li YL, Hao LN, Dong
RC and Hou MD: Application of artificial intelligence in
osteoporosis: A review. Front Med (Lausanne).
12(1718554)2025.PubMed/NCBI View Article : Google Scholar
|
|
256
|
Xue C, Chu Q, Shi Q, Zeng Y, Lu J and Li
L: Wnt signaling pathways in biology and disease: Mechanisms and
therapeutic advances. Signal Transduct Target Ther.
10(106)2025.PubMed/NCBI View Article : Google Scholar
|
|
257
|
Xian Y, Liu B, Shen T, Yang L, Peng R,
Shen H, An X, Wang Y, Ben Y, Jiang Q and Guo B: Enhanced SIRT3
expression restores mitochondrial quality control mechanism to
reverse osteogenic impairment in type 2 diabetes mellitus. Bone
Res. 13(30)2025.PubMed/NCBI View Article : Google Scholar
|
